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Immature dendritic cells (DC) at the environmental interfaces, such as the skin, constantly survey the tissue for the
emergence of microbial products and pro-inﬂammatory mediators. Upon recognition of such ‘‘danger’’ signals,
they undergo dynamic reprogramming of gene expression and functions, the process known as DC maturation,
which plays critical roles in both innate and adaptive immune responses. Although DC have been shown to
discriminate different maturation stimuli by expressing stimulus-specific signature genes and unique phenotypic
and functional properties, underlying mechanisms for this extraordinary plasticity remain relatively unclear. We
hypothesized that DC might activate unique sets of transcription factors (TF) upon sensing different stimuli. To test
this hypothesis, we transduced a mouse epidermal-derived DC line XS106 to express the luciferase reporter gene
under the control of each of 15 different cis-enhancer elements. The resulting DC panels were then exposed to 14
different microbial, endogenous, environmental, and pharmacological agents that produced unique maturational
changes. This approach allowed systematic determination of TF activation proﬁles in DC. Our results revealed
striking diversity, with different classes of stimuli triggering preferential activation of distinct sets of TF. We
propose that differential TF usage represents a previously unrecognized mechanism regulating the direction of DC
maturation.
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Dendritic cells (DC) are broadly distributed to environmental
interfaces, such as the skin, where they constantly incor-
porate surrounding materials and survey the tissues for mi-
crobial invasion and pro-inflammatory signals (Banchereau
and Steinman, 1998). To accomplish the latter task, DC ex-
press various Toll-like receptors (TLR), which mediate the
recognition of microbial products, endogenous molecules,
and pharmacological agents (Takeda et al, 2003). DC also
use purinergic type-2 receptors (P2R) to detect extracellular
adenosine triphosphate (ATP) and adenosine diphosphate
(ADP) released by endothelial cells and epithelial cells in
response to various pathogenic stimuli (La Sala et al, 2003).
Cytokine receptors and Fc receptors expressed on DC fur-
ther harness them to recognize even broader spectra of
biological signals (Guermonprez et al, 2002). Coupling of
these receptors with relevant ligands induces dynamic and
coordinated changes in gene expression and cellular func-
tion, the process known as DC maturation. For example, DC
alter their surface phenotype, acquire a heightened T cell-
stimulatory capacity, migrate to draining lymph nodes, and
secrete many cytokines and chemokines. In essence, DC
activation is the initial and key event linking the innate and
adaptive immune responses (Banchereau and Steinman,
1998; Mellman and Steinman, 2001).
Most of the previous studies on DC maturation examined
mRNA expression profiles, phenotypic alteration, and/or
functional changes in DC following treatment with selected
agents. These studies have established the current view that
not only do DC detect a wide array of biological stimuli, they
also discriminate them by expressing stimulus-specific ‘‘sig-
nature’’ genes, exhibiting unique phenotypic and functional
properties, and eliciting tailored immune responses (d’Os-
tiani et al, 2000; Granucci et al, 2001; Huang et al, 2001).
Underlying mechanisms for this extraordinary plasticity re-
main, however, mostly unknown. We reasoned that different
DC-stimulatory agents might trigger differential activation of
particular sets of transcription factors (TF) in DC. In this re-
gard, DC have been reported to activate the nuclear factor-
kB (NF-kB) pathway in response to a variety of biological
stimuli (Table I). Conversely, blockade of NF-kB pathway
in DC resulted in a severely impaired antigen-presenting
Abbreviations: ADP, adenosine diphosphate; AP-1, activator pro-
tein-1; ATP, adenosine triphosphate; CRE, cAMP binding protein
responsive element; CrO, croton oil; DC, dendritic cell; GAS, g-
interferon-activation sequence; IFN, interferon; ISRE, interferon-
stimulated responsive element; LPS, lipopolysaccharide; Luc,
luciferase; MIP, macrophage inflammatory protein; NFAT, nuclear
factor of activated T-cells; NF-kB, nuclear factor-kB; ODN, oligo-
deoxynucleotide; P2R, purinergic type 2 receptor; PMA, phorbol
myristate acetate/phorbol ester-sensitive element; RIU, relative in-
duction unit; STAT, signal transducer and activator of transcription;
TF, transcription factor; TLR, Toll-like receptor
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capacity (Giannoukakis et al, 2000; Yoshimura et al, 2001).
Thus, NF-kB-dependent gene transactivation cascades play
important roles in DC maturation. On the other hand, only
sporadic reports are available with respect to the activation
of a few other selected TF (activator protein-1 (AP-1), signal
transducer and activator of transcription STAT 3, and STAT 4
in DC (Table I). It is unlikely that these observations fully
represent the entire spectrum of TF activation profiles in-
volved in DC maturation because Hacker et al (2003) have
detected constitutive and/or induced mRNA expression of
4400 TF in DC at various differentiation stages.
In this study, we have developed a DC-based assay sys-
tem to gain a broader view of TF activation profiles upon
sensing diverse DC-stimulatory signals. Our results demon-
strate that different classes of biological stimuli preferentially
activate distinct sets of TF, with the implication that differ-
ential TF usage may represent a novel mechanism for pro-
ducing phenotypic and functional plasticity in a given DC
population.
Results and Discussion
Phenotypic and functional plasticity of the indicator DC
line We assembled a TF profiling system using an epider-
mal-derived DC line (XS106) derived from newborn A/J
mice. This DC line resembles Langerhans cells not only by
the tissue of origin but also by the cell surface phenotype
and function (Timares et al, 1998; Matsue et al, 1999). We
chose XS106 DC as an indicator DC line because it re-
sponds to various biological signals by altering immuno-
logical properties. For example, interferon g (IFNg), ATP,
ADP, croton oil (CrO, an environmentally hazardous
chemical known to cause skin irritation), and bacterial
Table I. TF activation proﬁles reported in DC
Receptors Ligands TF References
TLR superfamily
TLR2 Monophosphoryl lipid A NF-kB Ismaili et al (2002)
TLR2 Bacterial lipoprotein NF-kB Horng et al (2002)
TLR4 LPS NF-kB Rescigno et al (1998)
TLR4 Hyaluronan fragments NF-kB Termeer et al (2002)
TLR4 Heparan sulfate fragments NF-kB Johnson et al (2002)
TLR7 Guanosine analogs NF-kB Lee et al (2003)
TLR9 CpG oligonucleotides NF-kB Johnson et al (2002)
TLR9 CpG oligonucleotides AP-1 Hacker et al (1998)
TNFR superfamily
TNFR TNFa NF-kB Oyama et al (1998)
CD40 CD40L NF-kB Mann et al (2002)
CD40 CD40L AP-1 Mann et al (2002)
RANK RANKL NF-kB Wong et al (1998)
Other receptors
IL-12R IL-12 NF-kB Grohmann et al (1998)
IL-12R IL-12 STAT3 Nagayama et al (2000)
IL-12R IL-12 STAT4 Nagayama et al (2000)
GM-CSFR GM-CSF NF-kB Cruz et al (2001)
FceRI IgEþ anti-IgE NF-kB Kraft et al (2002)
FcgRII Immobilized IgG NF-kB Ba´nki et al (2003)
CD44 Hyaluronan polymer NF-kB Yang et al (2002)
CD44 Chondroitin sulphate A NF-kB Yang et al (2002)
CD91 Heat shock protein gp96 NF-kB Basu et al (2000)
Neurokinin-1R Substance P NF-kB Marriott et al (2000)
ND b2-microglobulin STAT3 Xie et al (2003)
ND Phorbol ester NF-kB Davis et al (1998)
ND Calcium ionophore NF-kB Lyakh et al (2000)
ND, not determined; TF, transcription factor; TLR, Toll-like receptor; DC, dendritic cell; NF-kB, nuclear factor-kB; LPS, lipopolysaccharide; TNFR, TNF
receptor; AP-1, activator protein-1; RANKL, receptor activator of NF-KB ligand; STAT, signal transducer and activator of transcription.
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lipopolysaccharide (LPS) differentially regulated the surface
phenotype and cytokine/chemokine production (Fig 1). LPS
was far more potent than other agents in elevating the
surface expression of MHC class II molecules and CD86
and triggering the secretion of TNFa, IL-6, IL-12 p40, and
macrophage inflammatory protein (MIP)-1a (LPS4CrO4
ATP¼ADP4IFNg). Interestingly, LPS and CrO augmented
MIP-1a production (LPS4CrO), whereas IFNg, ATP, and
ADP at low concentrations significantly suppressed the
production of this chemokine. CrO, ATP, and ADP were
found, at least, to be as efficient as LPS in promoting the
production of vascular endothelial growth factor (VEGF).
Thus, XS106 DC exhibit marked phenotypic and functional
plasticity upon activation with diverse stimuli. These results
are consistent with our recent finding that XS106 DC ex-
press distinct sets of signature genes upon exposure to the
above stimuli (data not shown).
Baseline activities of multiple transcription-regulatory
pathways The XS106 DC line was next transduced tran-
siently with a panel of luciferase (Luc) constructs containing
15 different cis-enhancer elements. In the absence of ex-
ogenous stimuli, many of these constructs induced signif-
icantly (po0.01) higher baseline Luc expression than did
the negative control construct containing no enhancers (Fig
2). For example, the NF-kB channel showed 10-fold higher
baseline expression levels above the negative control chan-
nel, corroborating the report that all tested NF-kB subunits
(RelB, p50, and p65) are detectable at high levels in the
nuclear extracts prepared from non-stimulated DC (Granelli-
Piperno et al, 1995). In addition, relatively high baseline
transcription activities were also observed in the cAMP
binding protein responsive element (CRE), phorbol myri-
state acetate/phorbol ester-sensitive element (PMA), and
Myc channels. These results indicate that several TF are
constitutively active in the XS106 DC line.
Activation proﬁles of multiple transcription-regulatory
pathways upon stimulation The same DC panels were
subsequently examined for Luc expression after exposure to
various stimuli. To compare the extent of stimulus-specific
induction, Luc expression levels in the test samples treated
with exogenous stimuli were divided by the baseline levels in
the untreated samples to calculate the relative induction
units (RIU). In agreement with the current notion that IFNg
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Figure 1
Phenotypic and functional plasticity of
the XS106 dendritic cell (DC) line. XS106
DC were treated for 24 h with the indicated
agents at the indicated concentrations.
These samples were then tested for the
surface expression or the secretion of the
indicated molecules. Data are representa-
tive of two independent experiments,
showing the mean  SD (n¼ 3 per group).
Asterisks or sharps indicate statistically
significant (po0.01) augmentation or inhi-
bition as compared with untreated con-
trols, respectively. Concentrations of test
agents are all plotted in log scales (x-axis),
and some outcome data sets are plotted
in different scales (y-axis) for individual
stimuli.
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activates JAK-STAT signaling cascades and leads to trans-
activation of many genes via IFN-stimulated responsive
element (ISRE) and g-IFN-activation sequence (GAS)
(Aaronson and Horvath, 2002), this cytokine produced 2-
fold induction of the ISRE channel and 6-fold induction of the
GAS channel, validating our experimental system (Fig 3A).
Extracellular ATP activated the CRE and PMA channels,
corroborating the previous report that ATP induces cAMP
production in DC (Wilkin et al, 2001). ATP also activated the
nuclear factor of activated T-cells (NFAT) channel (i.e., a
Ca2þ -dependent, calcineurin-mediated transcription-regu-
latory pathway). Although TLR-mediated NF-kB activation
in DC has been reported by many investigators (Table I),
LPS induced only modest (2-fold) induction of the NF-kB
channel, reflecting the relatively high baseline Luc expres-
sion in this channel (Fig 3). Our observation is in complete
agreement with the previous reports that DC constitutively
express relatively high NF-kB activities and exhibit only
modest and delayed NF-kB upregulation after LPS stimu-
lation (Ammon et al, 2000; Johnson et al, 2002). LPS also
activated several other channels including the AP-1 path-
way, which is known to be stimulated upon TLR ligation
(O’Neill, 2002). Necrotic keratinocytes activated many chan-
nels including CRE, PMA, and NFAT pathways, and CrO
stimulated an even broader spectrum of TF. A second P2R
ligand, ADP, predominantly activated the CRE, PMA, and
NFAT pathways, mimicking the profiles after ATP treatment
(Fig 3B). A second TLR ligand, CpG oligodeoxynucleotides
(ODN), also stimulated many channels, including the AP-1
pathway. By contrast, Pam 212 keratinocyte line, when
transduced with the same reporter plasmids, showed only
modest Luc expression after treatment with ADP or CpG
ODN, documenting DC specificity. It should be noted that
these agents (i.e., IFNg, ATP, ADP, LPS, CpG ODN, necrotic
keratinocytes, and CrO) caused only minimal Luc induction
in the enhancerless control channel, indicating the require-
ment of relevant cis-enhancer elements (top bars in Fig 3).
Moreover, none of these seven agents significantly upreg-
ulated the serum response element (SRE), Myc, p53, or Rb
channel above the baseline level, documenting channel
specificity (data not shown).
Concentration-dependency experiments revealed rela-
tively high sensitivity of our assay system, exhibiting signif-
icant Luc induction with 300 pg per mL IFNg (GAS channel),
15 mM ATP (CRE channel), 3 ng per mL LPS (NF-kB chan-
nel), 0.0003% CrO (PMA channel), or 15 mM ADP (NFAT
channel) (Fig 4A). Importantly, these concentration–re-
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Figure 2
Baseline activities of the tested transcription factors in XS106
dendritic cells (DC). XS106 DC were transduced with luciferase (Luc)
reporter constructs containing the indicated cis-enhancer elements and
examined for Luc expression 48 h later in the absence of added ex-
ogenous stimuli. Data are representative of six independent experi-
ments, showing the means  SD (n¼3) of relative Luc expression
levels of individual channels compared with the negative control chan-
nel with no enhancers. Statistically significant differences above the
negative control are indicated by asterisks (po0.01, po0.001).
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Figure 3
Stimulation-induced transcrip-
tion factor activation profiles. (A)
XS106 dendritic cells (DC) were
transduced with the indicated lucif-
erase (Luc) constructs and incubat-
ed for 24 h with interferon g (IFNg),
adenosine triphosphate (ATP), lip-
opolysaccharide (LPS), necrotic ker-
atinocytes, or croton oil (CrO). (B)
XS106 DC and Pam 212 keratin-
ocytes were transduced in parallel
with the indicated Luc constructs
and incubated for 24 h with ADP
or CpG oligodeoxynucleotides. The
data are representative of two inde-
pendent experiments, showing the
means  SD (n¼3) of relative in-
duction units (RIU) compared with
the untreated controls. Asterisks in-
dicate statistically significant in-
duction compared with the un-
treated controls (po0.1, po0.01,
po0.001).
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sponse curves were almost superimposable with those for
altering surface phenotype and cytokine/chemokine pro-
duction (Fig 1). In time-course experiments, these agents
activated the respective channels in similar kinetics with
significant signals detectable within 1.5–3 h and peak re-
sponses at 6–12 h, with the exception of LPS, which in-
duced NF-kB with delayed kinetics (Fig 4B). Not only do
these results validate the specificity and sensitivity of our
assay system, they also illustrate an extraordinary potential
of DC to activate selected TF rapidly upon encountering
minute amounts of immuno-regulatory agents.
Classiﬁcation of DC maturation stimuli based on TF ac-
tivation proﬁles By using this system, we have identified
14 stimuli that induced significant (po0.05) and substantial
(42-fold) upregulation of Luc expression at least in one
channel (Fig 5A). These stimuli include: (a) endogenous
molecules (ATP and ADP), (b) microbial products (LPS, CpG
ODN, muramyl dipeptide (DP), D-mannose, and Protein A),
(c) environmentally hazardous chemicals known to cause
skin irritation (CrO and ethyl phenylpropiolate (EPP)) (Mizu-
moto et al, 2002), (d) pharmacological agents (PMA and
Forskolin), (e) a cytokine (IFNg), (f) crude biological samples
(necrotic keratinocytes), and (g) physical stimulus (phago-
cytosis of latex beads). These results document the intrinsic
ability of DC to distinguish diverse biological signals at the
level of transcriptional regulation and the potential utility of
our assay system to classify these signals based on the TF
activation profiles. In fact, the hierarchical clustering anal-
ysis suggested that the tested stimuli may be divided into at
least three major clusters based on their Luc induction pro-
files: (a) a tight cluster of ATP and ADP; (b) IFNg showing a
distinct pattern; and (c) a relatively broad cluster consisting
of other 11 agents, in which LPS and CpG ODN were clus-
tered most closely.
Concluding remarks In summary, we have developed a
new assay system to determine activation profiles of mul-
tiple TF in DC in a systematic fashion. Our results demon-
strated striking diversity in which a given DC population
activated distinct sets of TF upon sensing different classes
of stimuli. For example, P2R ligands (ATP and ADP) pref-
erentially activated the CRE, NFAT, and PMA pathways in
DC, whereas TLR ligands (LPS and CpG ODN) stimulated
AP-1, NF-kB, and other channels more broadly (Fig 5B).
Although necrotic cells are known to induce DC maturation
(Gallucci et al, 1999), the underlying mechanisms remained
relatively unclear. Recently, necrotic cells have been shown
to release uric acid and high-mobility group B1 protein
(HMGB1), which, in turn, deliver DC-activation signals (Shi
et al, 2003; Rovere-Querini et al, 2004). We observed that
necrotic keratinocyte preparations activated the three P2R-
responsive channels (i.e., CRE, NFAT, and PMA pathways),
albeit less selectively. Considering the relatively high intra-
cellular ATP concentration (5–10 mM), it may be reasonable
to speculate that ATP leaked from necrotic cells may func-
tion as a third endogenous mediator of DC maturation.
It has been reported that DC can discriminate diverse
biological stimuli by expressing signature genes, acquiring
unique properties, and directing tailored immune respons-
es. Our observations now suggest an explanation for this
striking plasticity, that is, the direction of DC maturation may
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Figure 4
Concentration dependency and time-course of stimulus-specific transcription factor activation. (A) XS106 dendritic cells (DC) were trans-
duced with the indicated luciferase (Luc) constructs and incubated for 24 h with the reagents at the indicated concentrations (plotted in log scales).
(B) XS106 DC were transduced with the indicated Luc constructs and incubated for the indicated periods with interferon g (IFNg) (10 ng per mL),
adenosine triphosphate (ATP) (0.5 mM), lipopolysaccharide (LPS) (100 ng per mL), croton oil (CrO) (0.01%), or ADP (0.5 mM). The data in this figure
are representative of two independent experiments, showing the means  SD (n¼3) of relative induction units (RIU) compared with the untreated
controls. Asterisks indicate statistically significant induction as compared with the untreated controls (po0.01, po0.001).
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be governed at least partially by the profile of TF activated
by a given stimulus. It is equally important to state the pit-
falls of this study. Firstly, we used, throughout the study, a
single Langerhans cell-like DC line XS106 derived from
mouse epidermis. Considering marked heterogeneity
among different DC subsets in terms of the surface pheno-
types (including the TLR profiles) and functions (Shortman
and Liu, 2002), it will be interesting to determine whether
they may exhibit unique TF activation profiles following
exposure to the same stimulus. Secondly, our experimental
approach did not allow us to determine the composition of
multi-subunit TF (e.g., NF-kB, STAT, and AP-1). This is a
critical issue because different NF-kB subunits, for exam-
ple, play differential roles in DC development and activation
(Grumont et al, 2001; Ouaaz et al, 2002). Finally, our work
should be regarded as the first step toward complete un-
derstanding of activation profiles and functions of 4400 TF
potentially produced in DC (Hacker et al, 2003). Neverthe-
less, we believe that our results provide important insights
into molecular mechanisms by which DC discriminate po-
tentially harmful agents in order to elicit most desired types
of immune protection.
Materials and Methods
Cells The XS106 DC line was established from the epidermis of
newborn A/J mice and its phenotypic and functional features are
described elsewhere (Timares et al, 1998; Matsue et al, 1999).
XS106 DC were expanded in complete RPMI-1640 in the presence
of 0.5 ng per mL murine GM-CSF and 5% NS47 fibroblast-con-
ditioned medium (Matsue et al, 1999). Pam 212 keratinocytes were
cultured in complete culture medium in the absence of added
growth factors (Mizumoto et al, 2002).
TF activation proﬁling Luc expression constructs in the Mercury
Pathway Profiling Systems (BD Biosciences Clontech, Palo Alto,
California) were used in this study. Briefly, Luc coding sequence
with the TATA-like region from the thymidine kinase promoter was
inserted downstream from each of the different cis-acting enhanc-
er elements for: (a) AP-1 (containing four AP-1-binding sequences
of (TGAGTCAG)2 and (TGAGTCAC)2), (b) CRE ((GACGTCA)2 and
(GCCGTCA)), (c) glucocorticoid responsive element (GRE) ((GGTA-
CATTTTGTTCT)2 and (AGAACAAAATGTACC)), (d) heat shock
factor element (HSE) ((CTAGAACATTCTAG)2 and (CTAGAATGTTC-
TAG)), (e) NF-kB ((GGGAATTTCC)3), (f) E2F ((CTTGGCGGGAGA-
TAGAA)4), (g) ISRE ((GAAACTGAAACT)5), (h) PMA ((TGACTAAT)6),
(i) NFAT ((GGAGGAAAAACTGTTTCATACAGAAGGCGT)3), (j) STAT3
((TGCTTCCCGAACGT)4), (k) GAS ((AGGTTTCCGGGAAAGC)2 and
(AGGTTTCCGGGAAAGC)), (l) SRE ((GATGTCCATATTAGGACATC)2
and (GATGTCCGAATATGGACATC)), (m) Myc ((CACGTG)6), (n) Rb
((CCCGCGCGCCACCCCTCTGGCGCCACCGTG)2), and (o) p53
((ACGTTTGCCTTGCCTGGACTTGCCTGGCCTTGCCTT) and (GG-
ACATGCCCGGGCTGTC)). Luc plasmids with no enhancer ele-
ments served as negative control channels. XS106 DC were cul-
tured for 24 h in complete RPMI-1640 in the absence of added
growth factors on six-well plates (7  105 cells per well), trans-
fected with each of the above Luc plasmids using FuGENE (Roche
Diagnostics, Indianapolis, Indiana), and treated with each test agent
24 h after transfection. The samples were examined for Luc ex-
pression 24 h after stimulation unless otherwise specified. To eval-
uate the impact of a test agent on TF activities, we then calculated
the RIU values by dividing the induced Luc activities (after stim-
ulation) by the baseline Luc activities (without any stimulation).
DC-stimulatory agents The following agents were tested at the
indicated concentrations unless otherwise mentioned: IFNg (10 ng
per mL), ATP (0.5 mM), ADP (0.5 mM), LPS from Escherichia coli
(100 ng per mL), CpG ODN 1668 (50-TCCATGACGTTCCTGATGCT-
30) (1 mM), necrotic Pam 212 keratinocytes prepared by repeated
freeze-and-thaw procedures (106 cells per mL), CrO (0.01% vol/
vol), EPP (0.0001% vol/vol), muramyl DP (100 mg per mL), D(þ )-
mannose (25 mM), Protein A (10 mg per mL), PMA (180 ng per mL),
Forskolin (5 mM), and latex particles with 1 mm diameter (109 beads
per mL). These reagents were purchased from Sigma (St Louis,
Missouri), Calbiochem (Warrington, Pennsylvania), or Polysciences
(La Jolla, California). None of the test reagents, except for LPS,
contained detectable amounts of endotoxin as tested by the
QCL-1000 system (Bio Whittaker, Walkersville, Maryland). None of
the reagents significantly affected the viability of XS106 DC at the
tested concentrations as determined by propidium iodide uptake.
Surface phenotype and cytokine/chemokine production XS106
DC were incubated for 24 h with test agents and then analyzed for
surface phenotype by FACS and cytokine/chemokine production
by ELISA.
Statistical analysis Comparisons between two groups were per-
formed with a two-tailed Student’s t test, and more than two
groups were compared by analysis of variance (ANOVA). Each ex-
periment was repeated at least twice to assess reproducibility.
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Figure 5
Classification of dendritic cell (DC)-stimulatory signals based on
transcription factor activation profiles. (A) Data shown are the lucif-
erase induction profiles with the indicated channels (y-axis) following 24
h incubation with the indicated agents (x-axis). The color represents the
relative induction units compared with the untreated controls, accord-
ing to the shown scale. Data in this figure are representative of at least
two independent experiments for each stimulus and hierarchical clus-
tering was performed by using the GeneSpring program. (B) Differential
impacts of Toll-like receptors (TLR) ligands and P2R ligands on TF
activation profiles are illustrated. The line thickness represents the rel-
ative extent of activation of each TF.
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